Home > Boards > US Listed > Biotechs > Affimed Therapeutics (AFMD)

Slides from the Innate Killer Summit

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TwoNE1 Member Profile
 
Followed By 0
Posts 126
Boards Moderated 0
Alias Born 01/27/11
160x600 placeholder
Wells Fargo Says These 2 Stocks Could Spike Over 60% From Current Levels TipRanks - 4/23/2021 3:13:50 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/21/2021 5:28:49 PM
Amended Annual and Transition Report (foreign Private Issuer) (20-f/a) Edgar (US Regulatory) - 4/21/2021 4:41:06 PM
Affimed trades lower following FY bottom-line miss Seeking Alpha - 4/15/2021 11:49:39 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/15/2021 7:45:36 AM
Affimed EPS misses by €0.48, beats on revenue Seeking Alpha - 4/15/2021 6:37:12 AM
Affimed Reports 2020 Financial Results and Highlights Recent Operational Progress GlobeNewswire Inc. - 4/15/2021 6:30:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/14/2021 4:03:01 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4/14/2021 11:26:17 AM
Affimed shares gain 5% on encouraging AFM24 data in EGFR-expressing solid tumors Seeking Alpha - 4/12/2021 6:41:04 AM
Affimed Highlights the Potential of its Innate Cell Engager AFM24 as EGFR-targeting Therapy for Solid Tumors as Monotherapy a... GlobeNewswire Inc. - 4/12/2021 6:30:00 AM
Affimed shares rise 9% on positive data from NK cells + AFM13 in solid tumors Seeking Alpha - 4/9/2021 6:27:06 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/9/2021 6:16:18 AM
Affimed Announces Presentation at AACR Highlighting Initial Data from Phase 1 Study of Cord Blood-derived Natural Killer Cell... GlobeNewswire Inc. - 4/9/2021 5:59:00 AM
Affimed to Report Full Year 2020 Financial Results & Corporate Update on April 15, 2021 GlobeNewswire Inc. - 4/8/2021 6:30:00 AM
Affimed gets FDA green light to go ahead with AFM24+SNK-01 study in solid tumors, shares up 4% Seeking Alpha - 3/31/2021 6:50:23 AM
Affimed and NKMax America Announce FDA Clearance of IND Application to Study the Combination of AFM24, an EGFR Targeted Innat... GlobeNewswire Inc. - 3/31/2021 6:30:00 AM
Affimed Announces Presentations at the AACR Annual Meeting 2021 GlobeNewswire Inc. - 3/10/2021 5:22:00 PM
Affimed shares rise on continuation of REDIRECT study of AFM13 in T-cell cancer Seeking Alpha - 3/10/2021 7:10:46 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/10/2021 6:31:39 AM
Affimed Announces Continuation of REDIRECT, a Registration-directed Study of AFM13 in PTCL, after Positive Preplanned Interim... GlobeNewswire Inc. - 3/10/2021 6:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2021 5:28:29 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/10/2021 11:22:25 AM
Affimed N.V. rises 6.7% on ownership disclosure Seeking Alpha - 2/8/2021 6:03:37 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/8/2021 5:22:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences